​

Funding Round

Venture Round - Celularity

Venture Round - Celularity

Investment Firm

Overview

Celularity is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies.

Announced Date

Feb 15, 2018

Funding Type

Series Unknown

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

Celgene

Celgene

No designation

Participant Investors

9

Investor Name
Participant InvestorSorrento Therapeutics
Participant InvestorHeritage Group
Participant InvestorCelgene
Participant InvestorSection 32
Participant InvestorBill Maris

Round Details and Background

Celularity raised $250000000 on 2018-02-15 in Venture Round

Celularity is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies.

Company Funding History

4

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Sep 28, 2017
Series A - Celularity
2-40.0M
Feb 15, 2018
Venture Round - Celularity
9-250.0M
Jul 19, 2021
Post-IPO Equity - Celularity
3-80.0M
May 26, 2022
Post-IPO Equity - Celularity
-30.0M

Recent Activity

There is no recent news or activity for this profile.